ArticleFrontiers in immunology2024

Exploring inflammatory bowel disease therapy targets through druggability genes: a Mendelian randomization study.

Shuangjing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.